Correction to: Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)

Detalles Bibliográficos
Autores principales: Vehreschild, Maria J. G. T., Taori, Surabhi, Goldenberg, Simon D., Thalhammer, Florian, Bouza, Emilio, van Oene, Joop, Wetherill, Graham, Georgopali, Areti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315086/
https://www.ncbi.nlm.nih.gov/pubmed/30406879
http://dx.doi.org/10.1007/s10096-018-3410-8
_version_ 1783384207387525120
author Vehreschild, Maria J. G. T.
Taori, Surabhi
Goldenberg, Simon D.
Thalhammer, Florian
Bouza, Emilio
van Oene, Joop
Wetherill, Graham
Georgopali, Areti
author_facet Vehreschild, Maria J. G. T.
Taori, Surabhi
Goldenberg, Simon D.
Thalhammer, Florian
Bouza, Emilio
van Oene, Joop
Wetherill, Graham
Georgopali, Areti
author_sort Vehreschild, Maria J. G. T.
collection PubMed
description
format Online
Article
Text
id pubmed-6315086
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-63150862019-01-11 Correction to: Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE) Vehreschild, Maria J. G. T. Taori, Surabhi Goldenberg, Simon D. Thalhammer, Florian Bouza, Emilio van Oene, Joop Wetherill, Graham Georgopali, Areti Eur J Clin Microbiol Infect Dis Correction Springer Berlin Heidelberg 2018-11-08 2019 /pmc/articles/PMC6315086/ /pubmed/30406879 http://dx.doi.org/10.1007/s10096-018-3410-8 Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Correction
Vehreschild, Maria J. G. T.
Taori, Surabhi
Goldenberg, Simon D.
Thalhammer, Florian
Bouza, Emilio
van Oene, Joop
Wetherill, Graham
Georgopali, Areti
Correction to: Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)
title Correction to: Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)
title_full Correction to: Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)
title_fullStr Correction to: Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)
title_full_unstemmed Correction to: Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)
title_short Correction to: Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)
title_sort correction to: fidaxomicin for the treatment of clostridium difficile infection (cdi) in at-risk patients with inflammatory bowel disease, fulminant cdi, renal impairment or hepatic impairment: a retrospective study of routine clinical use (anemone)
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315086/
https://www.ncbi.nlm.nih.gov/pubmed/30406879
http://dx.doi.org/10.1007/s10096-018-3410-8
work_keys_str_mv AT vehreschildmariajgt correctiontofidaxomicinforthetreatmentofclostridiumdifficileinfectioncdiinatriskpatientswithinflammatoryboweldiseasefulminantcdirenalimpairmentorhepaticimpairmentaretrospectivestudyofroutineclinicaluseanemone
AT taorisurabhi correctiontofidaxomicinforthetreatmentofclostridiumdifficileinfectioncdiinatriskpatientswithinflammatoryboweldiseasefulminantcdirenalimpairmentorhepaticimpairmentaretrospectivestudyofroutineclinicaluseanemone
AT goldenbergsimond correctiontofidaxomicinforthetreatmentofclostridiumdifficileinfectioncdiinatriskpatientswithinflammatoryboweldiseasefulminantcdirenalimpairmentorhepaticimpairmentaretrospectivestudyofroutineclinicaluseanemone
AT thalhammerflorian correctiontofidaxomicinforthetreatmentofclostridiumdifficileinfectioncdiinatriskpatientswithinflammatoryboweldiseasefulminantcdirenalimpairmentorhepaticimpairmentaretrospectivestudyofroutineclinicaluseanemone
AT bouzaemilio correctiontofidaxomicinforthetreatmentofclostridiumdifficileinfectioncdiinatriskpatientswithinflammatoryboweldiseasefulminantcdirenalimpairmentorhepaticimpairmentaretrospectivestudyofroutineclinicaluseanemone
AT vanoenejoop correctiontofidaxomicinforthetreatmentofclostridiumdifficileinfectioncdiinatriskpatientswithinflammatoryboweldiseasefulminantcdirenalimpairmentorhepaticimpairmentaretrospectivestudyofroutineclinicaluseanemone
AT wetherillgraham correctiontofidaxomicinforthetreatmentofclostridiumdifficileinfectioncdiinatriskpatientswithinflammatoryboweldiseasefulminantcdirenalimpairmentorhepaticimpairmentaretrospectivestudyofroutineclinicaluseanemone
AT georgopaliareti correctiontofidaxomicinforthetreatmentofclostridiumdifficileinfectioncdiinatriskpatientswithinflammatoryboweldiseasefulminantcdirenalimpairmentorhepaticimpairmentaretrospectivestudyofroutineclinicaluseanemone

Ejemplares similares